Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2020 | 1 |
2021 | 1 |
2023 | 1 |
2024 | 0 |
Search Results
3 results
Results by year
Filters applied: . Clear all
Page 1
Features and Long-Term Outcomes of Stage IV Melanoma Patients Achieving Complete Response Under Anti-PD-1-Based Immunotherapy.
Am J Clin Dermatol. 2023 May;24(3):453-467. doi: 10.1007/s40257-023-00775-7. Epub 2023 May 4.
Am J Clin Dermatol. 2023.
PMID: 37142875
Free PMC article.
Primary Resistance to PD-1-Based Immunotherapy-A Study in 319 Patients with Stage IV Melanoma.
Amaral T, Seeber O, Mersi E, Sanchez S, Thomas I, Meiwes A, Forschner A, Leiter U, Eigentler T, Keim U, Garbe C.
Amaral T, et al. Among authors: seeber o.
Cancers (Basel). 2020 Apr 22;12(4):1027. doi: 10.3390/cancers12041027.
Cancers (Basel). 2020.
PMID: 32331243
Free PMC article.
Item in Clipboard
Association between Immune-Related Adverse Events and Survival in 319 Stage IV Melanoma Patients Treated with PD-1-Based Immunotherapy: An Approach Based on Clinical Chemistry.
Serna-Higuita LM, Amaral T, Forschner A, Leiter U, Flatz L, Seeber O, Thomas I, Garbe C, Eigentler TK, Martus P.
Serna-Higuita LM, et al. Among authors: seeber o.
Cancers (Basel). 2021 Dec 6;13(23):6141. doi: 10.3390/cancers13236141.
Cancers (Basel). 2021.
PMID: 34885249
Free PMC article.
Item in Clipboard
Cite
Cite